Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Chuangnuo Pharmaceutical is a prominent Chinese pharmaceutical company and a key subsidiary of the Acebright Group. The company focuses on the development and large-scale production of active pharmaceutical ingredients (APIs) and finished drug products, with a particular emphasis on anti-retroviral (ARV) medications for HIV/AIDS. Their manufacturing facilities are compliant with international standards, including WHO-PQ and US FDA requirements, enabling them to supply global health programs. In addition to anti-infectives, the company maintains a presence in the oncology and nutritional supplement sectors. Jiangsu Chuangnuo is recognized as a critical supplier for international procurement agencies such as the Global Fund and PEPFAR.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Chuangnuo Pharmaceutical.